Newsroom

The Ottawa Hospital manufactures COVID-19 vaccines for clinical trials
February 25, 2021 - The Ottawa Hospitalís Biotherapeutics Manufacturing Centre (BMC) is manufacturing three COVID-19 vaccines for human clinical trials, filling a critical gap in Canadaís vaccine manufacturing capacity.
Sepsis costs Ontario healthcare system $1 billion per year
February 22, 2021 - A study published in Critical Care Medicine led by researchers at The Ottawa Hospital, the University of Ottawa, and ICES shows that severe sepsis is linked with higher mortality, increased hospital readmission and higher healthcare costs. In ...
When Is Dead Really Dead?
February 17, 2021 - Researchers at The Ottawa Hospital played a major role in a CHEO-led study published in the New England Journals of Medicine. The study, led by Dr. Sonny Dhanani, asked over 600 families to allow their loved ones in the ICU to have their vital ...
Blood thinners help keep hospitalized COVID-19 patients out of ICU
February 17, 2021 - Full-dose blood thinners reduced the need for mechanical ventilation and transfer to the ICU in moderately ill patients hospitalized with COVID-19, according to interim results from an international clinical trial.
Stem cell treatment for scleroderma improves quality of life
February 17, 2021 - When Dr. Nancy Maltez meets a patient with early severe systemic scleroderma, a rare autoimmune disease that hardens the skin and organs, she knows one of the best options is to reset their immune system using strong chemotherapy and a stem cell ...
See all news items | See only press releases
Media contacts

Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
613-798-5555 x 73687
ambuchanan@ohri.ca

Jennifer Ganton
Director, Communications and Public Relations,
Ottawa Hospital Research Institute
613-737-8899 x 73325
jganton@ohri.ca

Ottawa Hospital Facebook linkOttawa Hospital Twitter linkOttawa Hospital YouTube link

Media resources
OHRI Fact Sheet
OHRI Annual Report